Aspireo Pharmaceuticals is Pharmaceuticals in Israel that focus on novel somatostatin analog business. Founded in 2010. They cover business area such as developer, somatostatin analog, disease, hormone-active tumor, Somatoprim, patient, disorder, diabetic retinopathy.
2010
( 14 years old in 2024 )
Novel Somatostatin Analog
-
PO Box 880
Ra'anana 43108
Israel
Private
developersomatostatin analogdiseasehormone-active tumorSomatoprimpatientdisorderdiabetic retinopathy
* We use standard office opening hours in near Aspireo Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Aspireo Pharmaceuticals is Pharmaceuticals business from Israel that founded in 2010 (14 years old in 2024), Aspireo Pharmaceuticals business is focusing on Novel Somatostatin Analog.
Aspireo Pharmaceuticals headquarter office and corporate office address is located in PO Box 880 Ra'anana 43108 Israel.
Aspireo Pharmaceuticals was founded in Israel.
In 2024, Aspireo Pharmaceuticals is currently focus on novel somatostatin analog sector.
Above is snippet of Google Trends for "novel somatostatin analog" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Aspireo Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
